Wednesday, June 28, 2017


Preparing for the growing care needs of the future

Pulmonary Hypertension is a disease that has largely fallen through the cracks of the major specialities in both Australia and New Zealand. Although a relatively rare disease, statistics reveal an increase in those presenting with Pulmonary Hypertension including its rarest form, Pulmonary Arterial Hypertension (PAH).

Over the past 6 years, centres of ‘excellence’ have been established to deal with growing numbers of patients with PH in Australia and New Zealand. Although these centres have the ability to access the tests mandated by regulatory bodies, they do not always have the resources, personnel, time or infrastructure to deliver optimal service to patients with Pulmonary Hypertension.

It is in this environment the Pulmonary Hypertension Society of ANZ operates with a commitment to supporting sustainable models of care for patients in the future.


Members of the medical community with an interest in Pulmonary Hypertension are invited to join the PHSANZ - membership benefits currently include the ability to attend the Annual Scientific Meeting, Clear Air News letter, community and industry updates and scientific publication updates.
For a short time membership is free and you can join via this website.

PHSANZ Newsletter

Stay up to date with the latest society news and events - become a registered PHSANZ member to join our mailing list.


Achieving Key Steps in 2016

Continue to execute role out and analysis of PHSANZ PHT registry. The registry will be the biggest per capita registry in the world. We  would hope this registry will promote future research and provide vital information for governments in allocating resources for improved patient outcomes.

New 2015 Registry Update!

Click here (1mb PDF) to download the 2015 PHSANZ PHT registry report.

Copyright 2011 by PHSANZ